Upstream Bio Statistics

Total Valuation

Upstream Bio has a market cap or net worth of $922.93 million. The enterprise value is $809.80 million.

Market Cap	922.93M
Enterprise Value	809.80M

Important Dates

The next estimated earnings date is Friday, February 14, 2025, before market open.

Earnings Date	Feb 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Upstream Bio has 53.60 million shares outstanding. The number of shares has increased by 2.29% in one year.

Current Share Class	53.60M
Shares Outstanding	53.60M
Shares Change (YoY)	+2.29%
Shares Change (QoQ)	+5.63%
Owned by Insiders (%)	0.08%
Owned by Institutions (%)	36.13%
Float	29.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	24.90
Forward PS	440.05
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	366.92
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 20.90, with a Debt / Equity ratio of 0.01.

Current Ratio	20.90
Quick Ratio	20.39
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	$58,079
Profits Per Employee	-$1.83M
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	22.37
200-Day Moving Average	n/a
Relative Strength Index (RSI)	39.13
Average Volume (20 Days)	457,568

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Upstream Bio had revenue of $2.21 million and -$69.59 million in losses. Loss per share was -$24.30.

Revenue	2.21M
Gross Profit	2.21M
Operating Income	-65.78M
Pretax Income	-54.81M
Net Income	-69.59M
EBITDA	-65.72M
EBIT	-65.78M
Loss Per Share	-$24.30

Full Income Statement

Balance Sheet

The company has $220.66 million in cash and $1.94 million in debt, giving a net cash position of $218.72 million or $4.08 per share.

Cash & Cash Equivalents	220.66M
Total Debt	1.94M
Net Cash	218.72M
Net Cash Per Share	$4.08
Equity (Book Value)	220.56M
Book Value Per Share	-52.99
Working Capital	216.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$55.67 million and capital expenditures -$326,000, giving a free cash flow of -$56.00 million.

Operating Cash Flow	-55.67M
Capital Expenditures	-326,000
Free Cash Flow	-56.00M
FCF Per Share	-$1.04

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-2,980.34%
Pretax Margin	-2,419.44%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Upstream Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.29%
Shareholder Yield	-2.29%
Earnings Yield	-6.77%
FCF Yield	-5.44%

Analyst Forecast

The average price target for Upstream Bio is $56.50, which is 228.11% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$56.50
Price Target Difference	228.11%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	-7.60%
EPS Growth Forecast (5Y)	-33.25%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Upstream Bio has an Altman Z-Score of -0.83 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.83
Piotroski F-Score	2